What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major ...

Have you seen ads for the new low-dose COVID vaccine called mNEXSpike and wondered what it's all about? Us too! So we did ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

GENEVA – The World Health Organization (WHO) issued recommendations Tuesday regarding Moderna’s COVID-19 vaccine, including guidance for pregnant women. WHO says pregnant women should not receive the ...

NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.

More doses of Moderna’s COVID-19 vaccine could soon be available after the FDA revised how many doses could be available per vial, up to 50% more. The Food and Drug Administration authorized the ...

Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that it would reduce R&D spending by $4 billion by 2028. At the end of the ...

HHS Secretary Robert F. Kennedy Jr. doesn't believe mRNA vaccines for COVID-19 and flu work, so funding is shifting to virus-based vaccines Moderna's stock fell Wednesday after Health and Human ...

Moderna Inc. fell Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.